Who Paid My Doc
Aphexda
Drug Hematology Oncology
NDC 82737-073-01
General payments
$112,250
Research payments
$3,140,572
Through program year 2024, $112,250 in general payments and $3,140,572 in research payments were reported against Aphexda (Hematology Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $112,250 | 137 |
| 2024 | Research | $3,140,572 | 32 |
Breakdown
The top 5 of 88 recipients; each share is of general payments naming this product in 2024.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
137 general · 32 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.